Arrhythmias

On this page

⚡ The Cardiac Electrical Storm: Mastering Arrhythmia Fundamentals

Arrhythmias transform the heart's elegant electrical symphony into chaos, threatening hemodynamic collapse within seconds or silently increasing stroke risk over years. You'll master the mechanisms that generate abnormal rhythms, develop systematic pattern recognition to distinguish benign from life-threatening dysrhythmias, and command evidence-based treatment algorithms that save lives in critical moments. This lesson integrates electrophysiology, ECG interpretation, clinical decision-making, and therapeutic intervention into a unified framework that turns rhythm disturbances from diagnostic mysteries into manageable clinical challenges.

12-lead ECG showing normal sinus rhythm with clear P waves and QRS complexes

The Electrical Foundation: Cardiac Conduction Architecture

The heart's electrical system operates as a sophisticated biological pacemaker network, generating 60-100 beats per minute with remarkable consistency. The sinoatrial (SA) node fires at 0.5-2.0 Hz, creating the primary rhythm that coordinates 4-6 liters of blood flow per minute.

  • SA Node Dominance

    • Intrinsic rate: 60-100 bpm (sinus rhythm)
    • Automaticity threshold: -40 to -50 mV
    • Recovery time: 1200-1500 ms (normal SNRT)
      • Abnormal if >1800 ms (sinus node dysfunction)
      • Corrected SNRT >550 ms indicates pathology
  • AV Node Conduction

    • Normal PR interval: 120-200 ms
    • AV node delay: 100-120 ms (allows ventricular filling)
    • Refractory period: 400-500 ms
      • Protects ventricles from atrial rates >300 bpm
      • Decremental conduction slows with faster rates

📌 Remember: PQRST - Pacemaker (SA), QRS (ventricular), Recovery (T wave), Systole (QRS-T), Timing (intervals)

Cardiac conduction system anatomy showing SA node AV node bundle branches

Arrhythmia Classification Matrix

OriginRate RangeQRS WidthRegularityClinical SignificanceMortality Risk
Sinus60-100 bpm<120 msRegularPhysiologicMinimal
Atrial150-250 bpm<120 msVariableStroke riskLow-Moderate
Junctional40-60 bpm<120 msRegularBackup rhythmLow
Ventricular>150 bpm>120 msVariableHemodynamic collapseHigh
Heart Block<60 bpmVariableVariableSyncope/deathModerate-High

The electrical conduction system's precision enables the heart to maintain cardiac output across varying physiologic demands. Connect this electrical foundation through arrhythmia mechanisms to understand how disruptions create clinical emergencies.


⚡ The Cardiac Electrical Storm: Mastering Arrhythmia Fundamentals

🌪️ The Rhythm Disruption Engine: Arrhythmogenesis Mechanisms

Fundamental Arrhythmia Mechanisms

  • Enhanced Automaticity

    • Increased slope of phase 4 depolarization
    • Threshold potential: -40 mV (normal) vs -50 mV (enhanced)
    • Common triggers: catecholamines, hypoxia, electrolyte imbalance
      • Digitalis toxicity increases automaticity at >2.0 ng/mL
      • Hypokalemia <3.5 mEq/L enhances ectopic foci
  • Triggered Activity Mechanisms

    • Early afterdepolarizations (EADs): occur during phases 2-3
    • Delayed afterdepolarizations (DADs): occur after phase 4
    • Critical coupling interval: 300-600 ms for torsades initiation
      • QT prolongation >500 ms increases EAD risk 5-fold
      • Calcium overload triggers DADs at >200% normal

📌 Remember: RATE - Reentry (most common), Automaticity (enhanced), Triggered activity (afterdepolarizations), Escape rhythms

Reentry circuit diagram showing slow and fast pathways in AV node

Reentry Circuit Dynamics

Reentry accounts for >80% of clinically significant tachyarrhythmias, requiring three essential components for sustained circus movement:

  • Anatomical Requirements

    • Unidirectional block in one pathway
    • Slow conduction in alternate route
    • Recovery of blocked pathway before circuit completion
      • Critical path length: >22 cm for atrial flutter
      • Conduction velocity: <0.3 m/s sustains reentry
  • Functional Reentry Patterns

    • Leading circle diameter: 2-4 cm (minimum sustainable)
    • Wavelength = refractory period × conduction velocity
    • Spiral wave dynamics in atrial fibrillation
      • Multiple wavelets: 4-6 simultaneous in persistent AF
      • Dominant frequency: 6-8 Hz in left atrium
Reentry TypeCycle LengthPathwayTerminationRecurrence Rate
AVNRT300-400 msAV node dualAdenosine 95%30% annually
AVRT250-350 msAccessoryAdenosine 90%50% annually
Atrial Flutter200-250 msTricuspid isthmusCardioversion 98%80% at 1 year
VT (scar)400-600 msMyocardial scarAntiarrhythmics 60%90% without ICD

💡 Master This: Reentry requires the wavelength (refractory period × conduction velocity) to be shorter than the circuit path length - this principle explains why class I antiarrhythmics can both terminate and prevent reentrant arrhythmias

Understanding these mechanisms enables prediction of which arrhythmias will respond to specific interventions. Connect reentry dynamics through pattern recognition frameworks to master rapid arrhythmia identification.


🌪️ The Rhythm Disruption Engine: Arrhythmogenesis Mechanisms

🎯 The Rhythm Recognition Arsenal: Clinical Pattern Mastery

Wide complex tachycardia ECG showing ventricular tachycardia morphology

The "See This, Think That" Framework

  • Wide Complex Tachycardia (QRS >120 ms)

    • VT probability: 85% if age >35 years
    • SVT with aberrancy: 15% overall incidence
    • Hemodynamic stability: unreliable for differentiation
      • 40% of VT patients remain stable initially
      • Blood pressure >90 mmHg in 60% of VT cases
  • Narrow Complex Tachycardia (QRS <120 ms)

    • Regular rhythm: AVNRT (60%), AVRT (30%), atrial flutter (10%)
    • Irregular rhythm: Atrial fibrillation (95% probability)
    • Rate >220 bpm: suggests accessory pathway conduction
      • Maximum AV node conduction: 180-200 bpm in adults
      • Rates >250 bpm: pre-excited AF (medical emergency)

📌 Remember: WIDE - Wide = VT until proven otherwise, Irregular narrow = AF, Delta waves = WPW, Extremely fast = accessory pathway

Atrial fibrillation ECG showing irregularly irregular rhythm no P waves

Morphology-Based Discrimination

  • VT Morphology Criteria (Brugada Algorithm)

    • Step 1: AV dissociation present = VT (100% specific)
    • Step 2: Concordance V1-V6 = VT (96% specific)
    • Step 3: Morphology analysis in V1/V6
      • RBBB pattern: R >30 ms in V1 = VT
      • LBBB pattern: R >60 ms in V1 = VT
  • Accessory Pathway Recognition

    • Delta wave: slurred QRS upstroke <120 ms
    • Short PR interval: <120 ms (bypass AV node delay)
    • Pre-excited AF: irregular wide complex >250 bpm
      • Shortest RR interval <250 ms = high-risk pathway
      • Risk of VF: 0.15% annually in asymptomatic WPW
ArrhythmiaRate (bpm)RegularityQRS WidthKey FeatureEmergency Priority
Sinus Tach100-150Regular<120 msGradual onsetLow
AVNRT150-220Regular<120 msAbrupt onset/offsetModerate
Atrial Flutter150 (2:1 block)Regular<120 msSawtooth wavesModerate
Pre-excited AF>250Irregular>120 msVariable QRSCRITICAL
VT150-250Regular>120 msAV dissociationCRITICAL
VF>300ChaoticVariableNo organized QRSCRITICAL

💡 Master This: The "3 R's" of emergency arrhythmia assessment - Rate (>150 = urgent), Regularity (irregular wide = dangerous), Recognition (VT vs SVT determines treatment)

Pattern recognition mastery enables split-second therapeutic decisions. Connect these recognition frameworks through systematic discrimination tools to build comprehensive diagnostic expertise.


🎯 The Rhythm Recognition Arsenal: Clinical Pattern Mastery

⚖️ The Diagnostic Discrimination Matrix: Systematic Analysis Tools

Comparison ECG strips showing VT versus SVT with aberrancy morphology differences

The Comprehensive Discrimination Framework

  • Hemodynamic Assessment Limitations

    • Myth: VT always causes instability
    • Reality: 60% of VT patients maintain adequate blood pressure
    • Hemodynamic tolerance depends on:
      • LV function: EF <35% increases instability risk 3-fold
      • Rate: >200 bpm reduces tolerance regardless of rhythm
      • Duration: >30 minutes increases decompensation risk
  • Age-Based Probability Matrix

    • Age <35 years: SVT probability 70%, VT 30%
    • Age 35-50 years: SVT probability 40%, VT 60%
    • Age >50 years: SVT probability 15%, VT 85%
      • Prior MI history: VT probability increases to >95%
      • Structural heart disease: VT likelihood >90%

📌 Remember: AVOID - Age >50 = VT likely, VT if wide + irregular, Old MI = VT, Instability unreliable, Drugs can cause both

Advanced Morphology Analysis

ECG FeatureVT ProbabilitySVT ProbabilitySensitivitySpecificityClinical Action
AV Dissociation98%2%25%98%Treat as VT
Capture Beats100%0%8%100%Diagnostic of VT
Fusion Beats100%0%5%100%Diagnostic of VT
Concordance V1-V696%4%20%96%Highly suggestive VT
Axis Deviation85%15%60%85%Supportive of VT
  • RBBB Pattern in V1:

    • Monophasic R: VT (95% specific)
    • Triphasic rSR': SVT (90% specific)
    • R wave >30 ms: VT (85% sensitive)
  • LBBB Pattern in V1:

    • R wave >60 ms: VT (95% specific)
    • Notched downstroke: VT (85% specific)
    • QS or rS <70 ms: SVT (90% specific)

Response to Therapeutic Interventions

  • Adenosine Response Patterns

    • SVT termination: 95% of AVNRT/AVRT cases
    • No response: 98% probability of VT
    • Transient AV block: reveals underlying atrial arrhythmia
      • Atrial flutter: sawtooth waves become visible
      • Atrial tachycardia: discrete P waves at 150-250 bpm
  • Verapamil Response (AVOID in wide complex)

    • SVT: terminates 80% of cases
    • VT: can cause hemodynamic collapse in 40%
    • Pre-excited AF: may precipitate ventricular fibrillation

Clinical Pearl: Capture beats (narrow QRS during wide complex tachycardia) are 100% diagnostic of VT but occur in only 8% of cases - when present, they're pathognomonic

💡 Master This: The "Rule of 4's" for wide complex tachycardia - if 4+ VT criteria are present (age >50, prior MI, AV dissociation, concordance), treat as VT with >95% confidence

Systematic discrimination prevents therapeutic disasters and guides evidence-based management. Connect these analytical frameworks through treatment algorithms to master therapeutic decision-making.


⚖️ The Diagnostic Discrimination Matrix: Systematic Analysis Tools

🚀 The Therapeutic Command Center: Evidence-Based Treatment Algorithms

Defibrillator paddles positioned for cardioversion with synchronized mode

Acute Arrhythmia Management Protocols

  • Immediate Cardioversion Indications

    • Hemodynamic instability: SBP <90 mmHg
    • Acute heart failure: pulmonary edema, cardiogenic shock
    • Chest pain: ongoing ischemia with arrhythmia
    • Altered mental status: cerebral hypoperfusion
      • Success rate: >95% for organized rhythms
      • Energy requirements: 100-200J for SVT, 200J for VT
  • Pharmacological Intervention Hierarchy

    • First-line narrow complex: Adenosine 6mg IV push

      • Success rate: 85% first dose, 95% with second 12mg dose
      • Half-life: <10 seconds (must give rapidly through large IV)
      • Contraindications: asthma, 2nd/3rd degree AV block
    • First-line wide complex: Amiodarone 150mg IV over 10 minutes

      • VT termination: 60-70% within 24 hours
      • Maintenance: 1mg/min × 6 hours, then 0.5mg/min
      • Alternative: Procainamide 20-50mg/min (avoid if CHF)

Rate Control vs Rhythm Control Strategies

ArrhythmiaRate ControlRhythm ControlSuccess RateRecurrenceLong-term Strategy
Atrial FibrillationMetoprolol 25-100mg BIDAmiodarone 400mg daily80% vs 60%50% vs 70%Rate preferred >65 years
Atrial FlutterDiltiazem 120-240mg dailyCardioversion70% vs 95%80% vs 60%Rhythm preferred
AVNRTVerapamil 240mg dailyAblation85% vs 98%30% vs 5%Ablation preferred
VT (stable)Not applicableAmiodarone/AblationN/A vs 80%N/A vs 20%ICD + ablation
  • Atrial fibrillation: resting HR <110 bpm (lenient control)
  • Strict control: <80 bpm rest, <110 bpm exercise
  • Heart failure patients: target 60-100 bpm
    • Beta-blockers: mortality benefit in AF with HFrEF
    • Digoxin: neutral mortality, avoid in women
  • Anticoagulation Decision Framework
    • CHA₂DS₂-VASc Score: guides anticoagulation in AF
      • Score ≥2: anticoagulation recommended (Class I)
      • Score 1: consider anticoagulation (Class IIa)
      • Score 0: no anticoagulation needed
    • Bleeding risk: HAS-BLED score ≥3 = high risk
      • 3.7% annual major bleeding with warfarin
      • 2.1% annual major bleeding with DOACs

Advanced Therapeutic Interventions

  • Catheter Ablation Success Rates

    • AVNRT: 98% success, <1% recurrence
    • AVRT: 95% success, 5% recurrence
    • Atrial flutter: 95% success, 10% recurrence
    • VT (ischemic): 70% success, 30% recurrence
      • Complications: 2-5% major, <0.5% mortality
      • Procedure time: 2-6 hours depending on complexity
  • Device Therapy Indications

    • ICD primary prevention: EF ≤35% on optimal medical therapy
    • ICD secondary prevention: survived VT/VF arrest
    • CRT-D: EF ≤35%, QRS ≥150ms, LBBB morphology
      • 30% mortality reduction with appropriate ICD therapy
      • 25% reduction in heart failure hospitalizations with CRT

Clinical Pearl: Synchronized cardioversion uses 50-75% less energy than unsynchronized shocks and reduces risk of inducing ventricular fibrillation from 15% to <1%

💡 Master This: The "ABCD" of arrhythmia management - Assess stability, Broad vs narrow complex, Cardioversion if unstable, Drugs if stable - this sequence prevents therapeutic errors in >95% of cases

Evidence-based algorithms ensure optimal outcomes across diverse clinical scenarios. Connect these treatment frameworks through multi-system integration to understand complex arrhythmia interactions.


🚀 The Therapeutic Command Center: Evidence-Based Treatment Algorithms

🔗 The Arrhythmia Ecosystem: Multi-System Integration Mastery

Cardiovascular-Neurohormonal Integration

  • Autonomic Nervous System Modulation

    • Sympathetic stimulation: increases automaticity, shortens refractory periods
    • Parasympathetic activation: prolongs AV conduction, increases refractoriness
    • Circadian patterns: 6 AM-12 PM peak for sudden cardiac death
      • 40% of VT/VF episodes occur during morning hours
      • Cortisol surge increases catecholamine sensitivity by 300%
  • Heart Failure-Arrhythmia Interactions

    • Structural remodeling: creates slow conduction zones for reentry
    • Electrical remodeling: alters ion channel expression
    • AF in heart failure: increases mortality by 15-20%
      • Tachycardia-induced cardiomyopathy: EF improves >15% with rate control
      • CRT response: reduced by 50% in persistent AF

📌 Remember: HEART - Hormones affect rhythm, Electrolytes alter conduction, Autonomics modulate rate, Remodeling creates substrate, Timing determines outcomes

Electrolyte-Arrhythmia Relationships

ElectrolyteNormal RangeArrhythmia RiskECG ChangesTreatment TargetMonitoring Frequency
Potassium3.5-5.0 mEq/L<3.0 or >6.0U waves, peaked T4.0-4.5 mEq/Lq6h if abnormal
Magnesium1.7-2.2 mg/dL<1.5 mg/dLProlongs QT>2.0 mg/dLDaily
Calcium8.5-10.5 mg/dL<7.0 or >12.0QT changes8.5-10.0 mg/dLDaily
Phosphorus2.5-4.5 mg/dL<2.0 mg/dLIndirect effects>2.5 mg/dLDaily
  • Mechanism: enhanced phase 4 depolarization, prolonged repolarization
  • Risk threshold: <3.0 mEq/L increases VT risk 5-fold
  • Digitalis interaction: hypokalemia increases digitalis toxicity by 10-fold
    • Target K⁺ 4.0-4.5 mEq/L in digitalis patients
    • Replacement rate: 10-20 mEq/hour maximum IV
  • Magnesium Deficiency Syndromes
    • Torsades de pointes: Mg²⁺ <1.5 mg/dL in >80% of cases
    • Treatment: 2-4 grams IV magnesium sulfate over 15 minutes
    • Refractory hypokalemia: often requires magnesium repletion first
      • 60% of hypokalemic patients have concurrent hypomagnesemia
      • Magnesium normalizes Na⁺-K⁺-ATPase pump function

Drug-Arrhythmia Interactions

  • QT-Prolonging Medications

    • High risk: haloperidol, droperidol, sotalol, dofetilide
    • Moderate risk: amiodarone, quinidine, procainamide
    • Monitoring: baseline QTc, then q24h during initiation
      • QTc >500 ms: discontinue offending agent
      • ΔQTc >60 ms: significant prolongation requiring action
  • Proarrhythmic Effects

    • Class IC agents: 2.5-fold increase in mortality post-MI (CAST trial)
    • Antiarrhythmic paradox: 5-10% incidence of new arrhythmias
    • Digitalis toxicity: bidirectional VT, accelerated junctional rhythm
      • Therapeutic range: 0.8-2.0 ng/mL
      • Toxicity risk: >2.5 ng/mL in >90% of cases

Clinical Pearl: Magnesium sulfate terminates torsades de pointes in >90% of cases, even when serum magnesium levels are normal - it's the first-line therapy regardless of measured levels

💡 Master This: The "4 M's" of arrhythmia complexity - Metabolism (electrolytes), Medications (drug interactions), Mechanics (heart failure), Modulation (autonomics) - addressing all four domains optimizes treatment success

Multi-system integration reveals the complexity underlying arrhythmia management. Connect these interaction patterns through rapid mastery frameworks to build comprehensive clinical expertise.


🔗 The Arrhythmia Ecosystem: Multi-System Integration Mastery

🎯 The Arrhythmia Mastery Toolkit: Rapid Clinical Reference

Emergency cardiac monitor showing multiple arrhythmia patterns for recognition training

The Essential Numbers Arsenal

📌 Remember: CRITICAL 6 - 6mg adenosine, 6 seconds for VF, 60 bpm bradycardia threshold, 600 ms QT danger, 6 hours amiodarone loading, 6 months anticoagulation minimum

  • Emergency Thresholds

    • Heart rate: <60 bpm (bradycardia), >100 bpm (tachycardia)
    • Blood pressure: <90 mmHg systolic = unstable
    • QTc intervals: >500 ms = high torsades risk
    • Energy levels: 200J synchronized cardioversion, 360J defibrillation
      • Biphasic: 120-200J equivalent efficacy to 360J monophasic
      • Pediatric: 2 J/kg initial, 4 J/kg subsequent
  • Drug Dosing Quick Reference

    • Adenosine: 6mg12mg18mg IV push
    • Amiodarone: 150mg IV over 10 min, then 1mg/min × 6h
    • Metoprolol: 25-50mg BID, titrate to 200mg BID maximum
    • Diltiazem: 0.25 mg/kg IV, then 5-15 mg/hour infusion

Rapid Pattern Recognition Drills

ECG PatternRateRegularityQRSImmediate ActionSuccess Rate
Narrow regular >150150-220Regular<120msAdenosine 6mg95%
Wide regular >150150-250Regular>120msAssume VT, cardiovert98%
Irregular narrowVariableIrregular<120msRate control AF85%
Irregular wide >250>250Irregular>120msEMERGENCY cardiovert100%
No organized rhythm>300ChaoticNoneDefibrillate immediately90%

The Clinical Decision Matrix

  • The "STABLE" Assessment

    • Systolic BP >90 mmHg
    • Tolerating rhythm without distress
    • Alert and oriented mental status
    • Breathing without pulmonary edema
    • Lack of chest pain/ischemia
    • Effective cardiac output maintained
  • Post-Cardioversion Priorities

    • Anticoagulation: if AF >48 hours or unknown duration
    • Electrolyte optimization: K⁺ 4.0-4.5, Mg²⁺ >2.0
    • Rate control: prevent rapid recurrence
    • Rhythm monitoring: 24-48 hours minimum observation

💡 Master This: The "Rule of 200's" - QRS >120ms + rate >200 bpm + age >50 = treat as VT with >95% accuracy, avoiding the fatal error of giving AV nodal blockers to ventricular tachycardia

Long-Term Management Frameworks

  • Ablation Referral Criteria

    • Symptomatic SVT: after 2+ episodes despite medication
    • Atrial flutter: first-line therapy (>95% success rate)
    • AF with heart failure: if rate control inadequate
    • VT with ICD: >3 appropriate shocks in 24 hours
  • Anticoagulation Duration Guidelines

    • Cardioversion: 3 weeks before + 4 weeks after minimum
    • Persistent AF: lifelong if CHA₂DS₂-VASc ≥2
    • Post-ablation: 3 months minimum, then reassess stroke risk
    • Bleeding vs thrombosis: 2-3:1 ratio favors anticoagulation in most patients

The arrhythmia mastery toolkit transforms complex rhythm disturbances into systematic, evidence-based management approaches, ensuring optimal patient outcomes through rapid recognition and appropriate intervention strategies.

🎯 The Arrhythmia Mastery Toolkit: Rapid Clinical Reference

Practice Questions: Arrhythmias

Test your understanding with these related questions

A 44-year-old man comes to the emergency department because of persistent palpitations for the past 2 hours. The day before, he was at a wedding, where he drank several glasses of wine and 9–10 vodka cocktails. He has never had similar symptoms before. He is a manager at a software company and has recently had a lot of work-related stress. He is otherwise healthy and takes no medications. His temperature is 36.5°C (97.7°F), pulse is 90/min and irregularly irregular, respirations are 13/min, and his blood pressure is 128/60 mm Hg. Physical examination shows no other abnormalities. An ECG is performed; no P-waves can be identified. Echocardiography shows no valvular abnormalities and normal ventricular function. One hour later, a repeat ECG shows normal P waves followed by narrow QRS complexes. He is still experiencing occasional palpitations. Which of the following is the most appropriate next step in management?

1 of 5

Flashcards: Arrhythmias

1/10

Which thyroid imbalance presents with tachycardia, palpitations, and arrhythmias?_____

TAP TO REVEAL ANSWER

Which thyroid imbalance presents with tachycardia, palpitations, and arrhythmias?_____

Hyperthyroidism

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial